Cardiologia Italiana del Territorio
Cardiologia Italiana del Territorio
L’obiettivo terapeutico migliore dovrebbe stabilire i criteri cronologici ottimali di un intervento farmacologico. Seguendo l’attività biologica delle cellule precisi ritmi circadiani, esistono ore del giorno più o meno idonee alla somministrazione di...
p Nei pazienti con insufficienza cardiaca a frazione di eiezione ridotta, in ritmo sinusale o con concomitante fibrillazione atriale, la relazione tra frequenza cardiaca e mortalità non è sufficientemente chiarita. Una recente meta-analisi (dati provenienti da 11...
Nel studio SMILE-4 (Clin. Cardiol. 35, 7, 416-423, 2012), studio multicentrico europeo randomizzato in doppio cieco per gruppi paralleli, era stata confrontata l’efficacia e la sicurezza di due ACE-inibitori, zofenopril (60 mg/die) e ramipril (10 mg/die) in...
Punteggi predittivi per aiutare nella scelta terapeutica: lo score PRECISE DAPT Un aspetto da tempo dibattuto in cardiologia è costituito dalla durata della doppia aggregazione antipiastrinica (DAPT), ovvero l’aggiunta all’acido acetilsalicilico di una...
Importance Heart disease (HD) and cancer are the 2 leading causes of death in the United States. During the first decade of the 21st century, HD mortality declined at a much greater rate than cancer mortality and it appeared that cancer would overtake HD as the...
Abstract Objectives This study sought to investigate the associations of left ventricular (LV) strain and its serial change with major adverse cardiac events (MACE) in hypertensive heart disease, independent of and incremental to clinical and LV geometric...
lettera congiunta Società Scientifiche a Ministro Lorenzin 2-signed
Objective To study the effectiveness and safety of the non-vitamin K antagonist oral anticoagulants (novel oral anticoagulants, NOACs) dabigatran, rivaroxaban, and apixaban compared with warfarin in anticoagulant naïve patients with atrial fibrillation....
In 2013, the European Heart Rhythm Association (EHRA) published a Practical Guide on the use of non-VKA oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) (Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, Camm AJ,...
Background Patients with diabetes appear to be at elevated risk of atherothrombotic events. Objectives The purpose of this study was to determine the effect of antiplatelet therapy with ticagrelor on recurrent ischemic events in patients with diabetes and prior...
Direct oral anticoagulants (DOACs) have been used in clinical practice in the United States for the last 4 to 6 years. Although DOACs may be an attractive alternative to warfarin in many patients, long-term outcomes of use of these medications are unknown. We...
Cari soci Ance ho il piacere e l’onore , come anticipato alla riunione dei nostri quadri tenutasi il 22/23 aprile , di comunicarvi l’avvio di un importante studio, in cooperazione con l’AIAC, sulla fibrillazione atriale: lo studio FACT . A fine maggio...
Abstract Background Risk stratification in asymptomatic patients remains by far the most important yet unresolved clinical problem in the Brugada syndrome (BrS). Objectives This study sought to analyze the usefulness of electrocardiographic parameters as markers...
Most physician readers of Aro’s and Chugh’s elegant review of electrical and anatomic types of LVH and the implications will be puzzled by the concepts that electrical LVH (ECG/LVH) and anatomic LVH (echo/LVH and MRI/LVH) might be different entities, and that...
Patients with heart failure have a poor prognosis, yet outcomes might be improved by early identification of risk. Proenkephalin (proENK), a novel biomarker, is a stable surrogate marker for endogenous enkephalins and is an independent predictor of heart failure...
Dopo l’endorsement dei giorni scorsi ricevuto dello staff interno dell’Fda, lo scorso 15 gennaio il nuovo antiaggregante orale vorapaxar ha ricevuto il parere positivo degli esperti del Cardiovascular and Renal Drugs Advisory Committee dell’Fda. Con 10 voti a 1,...
Objectives The aim of this study was to describe current practice regarding completeness of revascularization in patients with multivessel disease undergoing percutaneous coronary intervention (PCI) and to investigate the association of incomplete...
Allopurinol lowers blood pressure in adolescents and has other vasoprotective effects. Whether similar benefits occur in older individuals remains unclear. We hypothesized that allopurinol is associated with improved cardiovascular outcomes in older adults with...
Si è concluso Giovedì 4 Febbraio il “Convention Consensus Document Intersocietaria”, tenutosi a Catania su iniziativa dell’A.N.M.C.O., che ha visto riunite le più importanti società scientifiche di area medica, di farmacologia, di biochimica clinica e di biologia...